PMA device
Volt PFA System
Abbott Medical · Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI, Class III) · First FDA decision Dec 19, 2025, newest Oct 15, 2026Atrial fibrillation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
7
Naming "Volt PFA"
MAUDE reports
0
Brand "Volt PFA", since 2015
PubMed studies
3
Mentioning "Volt PFA"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Volt PFA System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 4 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Left Atrial Appendage Closure (LAAC)National determinationOn the books20.34Updated Nov 4, 2026
- Percutaneous Left Atrial Appendage (LAA) Closure TherapyNational analysisReview closedCAG-00445NUpdated Sep 21, 2026
- Cardiac Catheterization Performed In Other Than A Hospital SettingNational analysisReview closedCAG-00166NUpdated Sep 16, 2026
- Cardiac Catheterization Performed in Other than a Hospital Setting - RETIREDNational determinationOn the books20.25Updated Dec 3, 2024
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33959CGS Administrators, LLCUpdated Oct 30, 2026
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33557Wellpoint FederalUpdated Jul 14, 2026
- Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back painLocal determinationIn effectL36000WPS Insurance CorporationUpdated May 21, 2026
- Irreversible Electroporation for CancerLocal determinationIn effectL40205Palmetto GBAUpdated May 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Volt PFA", any status and sponsor, newest update first.
- VOLT CE Mark StudyActive, not recruiting
Abbott Medical DevicesPublic (ABT)
NCT06106594 · 300 participants (planned) · Start Oct 24, 2023 · Primary completion Jan 2027
Device: Pulsed Field Ablation · For: Atrial Arrhythmia; Atrial Fibrillation; Paroxysmal Atrial Fibrillation and 1 more
Sites: Chermside, Australia; Adelaide, Australia; Clayton, Australia · 11 sites in all
Abbott Medical DevicesPublic (ABT)
NCT07523620 · 240 participants (planned) · Start Mar 31, 2026 · Primary completion May 31, 2027
Device: Left Atrial Appendage Occluder Implant · For: Atrial Fibrillation (AF); Paroxysmal AF; Persistent Atrial Fibrillation
Sites: Brussels, Belgium; Prague, Czechia; Copenhagen, Denmark · 16 sites in all
- BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAFActive, not recruiting
Abbott Medical DevicesPublic (ABT)
NCT07181590 · 300 participants · Start Dec 11, 2025 · Primary completion Sep 2027
Device: Pulsed Field Ablation · For: Paroxysmal AF; Atrial Arrhythmia; Atrial Fibrillation and 1 more
Sites: Linz, Austria; Bruges, Belgium; Brussels, Belgium · 22 sites in all
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Volt PFA", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QZI
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Volt PFA"[tiab]. The summary above synthesizes these.
- Safety and effectiveness of a novel balloon-in-basket pulsed-field ablation catheter for the treatment of paroxysmal and persistent AF: Volt-AF IDE trial acute results.
Lo M, Gambhir A, Sundaram S, et al. · Heart Rhythm · 2025Multicenter Study, Research Support, Non-U.S. Gov't
- Pulsed field ablation of the cavotricuspid isthmus using a balloon-in-basket system.
Kheir JA, Urbanek L, Urbani A, et al. · J Interv Card Electrophysiol · 2026Case Reports
- Initial clinical experience with the balloon-in-basket pulsed field ablation system: acute results of the VOLT CE mark feasibility study.
Sanders P, Healy S, Emami M, et al. · Europace · 2024Multicenter Study, Clinical Trial
Other devices of this type
Also filed under product code QZI.
- FARAPULSE Pulsed Field Ablation System (FARAWAVE Pulsed Field Ablation CatheterFarapulse, Inc. · PMA 2026
- VARIPULSE Catheter, TRUPULSE Generator with Connection Interface Unit (CIU)Biosense Webster, Inc. · PMA 2026
- Sphere-9 Catheter and Affera Ablation SystemMedtronic, Inc. · PMA 2026
- PulseSelect Pulsed Field Ablation (PFA) systemMedtronic, Inc. · PMA 2026
- Globe® Catheter and Globe® Pulsed Field SystemKardium, Inc. · PMA 2026
- PulseSelect Pulse Field Ablation (PFA) CatheterMedtronic, Inc. · PMA 2026
- FARASTAR Pulsed Field Ablation (PFA) GeneratorFarapulse, Inc. · PMA 2025
- Globe® Pulsed Field SystemKardium, Inc. · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.